La Crosse Encephalitis in Eastern Tennessee: Clinical, Environmental, and Entomological Characteristics from a Blinded Cohort Study

Paul C. Erwin1, Timothy F. Jones2, Reid R. Gerhardt3, Sandy K. Halford1, A. Brent Smith3, Lori E. R. Patterson4, Kristy L. Gottfried5, Kristen L. Burkhalter5, Roger S. Nasci5 and William Schaffner6

1 East Tennessee Regional Office, Tennessee Department of Health, Knoxville, TN.
2 Tennessee Department of Health, Nashville, TN.
3 Department of Entomology and Plant Pathology, University of Tennessee, Knoxville, TN.
4 East Tennessee Children's Hospital, Knoxville, TN.
5 Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, CO.
6 Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
A blinded cohort study was conducted in 2000 to better understand the emergence of La Crosse virus infection in eastern Tennessee, with special emphasis on the potential mosquito vector(s). Children with suspected central nervous system infection were enrolled at the time of clinical presentation at a large pediatric referral hospital. Clinical, environmental, and entomological data were collected prior to case confirmation. Sixteen of the 40 children included in the final analysis were confirmed to have La Crosse infection by a fourfold increase in antibody titers between collection of acute- and convalescent-phase sera. Factors significantly associated with La Crosse infection included average number of hours per day spent outdoors (5.9 for La Crosse virus cases vs. 4.0 for noncases, p = 0.049); living in a residence with one or more tree holes within 100 m (relative risk = 3.96 vs. no tree holes within 100 m, p = 0.028); and total burden of Aedes albopictus (number of female and male larvae and adults collected at a site), which was more than three times greater around the residences of La Crosse virus cases versus noncases (p = 0.013). Evidence is accumulating that the newly introduced mosquito species Ae. albopictus may be involved in the emergence of La Crosse virus infection in eastern Tennessee.

Aedes; arbovirus infections; arboviruses; central nervous system infections; immunologic surveillance; virus diseases

Abbreviations: CDC, Centers for Disease Control and Prevention


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
La Crosse virus infection is the most commonly reported arboviral disease, and the most frequently identified cause of pediatric encephalitis, in the United States (1Go, 2Go). La Crosse is the predominant virus of the California serogroup of Bunyaviruses and, in 2000, accounted for 109 reported cases of encephalitis (Centers for Disease Control and Prevention (CDC) provisional data; (3Go)). Although most infections with La Crosse virus are thought either to be asymptomatic or to result in mild flulike illnesses, the majority that come to the attention of the public health community are serious and result in emergency room visits and intensive care admissions (4Go, 5Go). Since the initial isolation of La Crosse virus from a human in the 1960s, most cases of La Crosse encephalitis have been reported from the upper Midwestern states, primarily Illinois, Iowa, Indiana, Minnesota, Ohio, and Wisconsin (4Go, 6Go). Over the past decade, the majority of reported cases have occurred in West Virginia; during this same time period, La Crosse encephalitis has also been reported from North Carolina (7Go, 8Go). Most recently, La Crosse infection has been newly identified in eastern Tennessee, with a range of six to 10 cases reported annually between 1997 and 1999 (9Go, 10Go).

Numerous studies have established Ochlerotatus (= Aedes) triseriatus (the eastern tree hole mosquito) as the primary vector for La Crosse virus (4Go, 11Go). This species is native to the geographic areas in which La Crosse virus infections have been reported. The virus can be transmitted within this mosquito species both vertically (transovarially) and horizontally (venereal); in addition, La Crosse virus may overwinter in Oc. triseriatus (12GoGo–14Go). A variety of mammals may serve as amplification hosts, including the eastern chipmunk (Tamias striatus), grey squirrel (Sciurus carolinensis), and red fox (Vulpes fulva) (4Go). Humans and white-tailed deer (Odocoileus virginianus) are considered incidental, or "dead-end," hosts that do not support viremia sufficiently well enough to infect other mosquitoes; however, since a blood meal may result in a gonadotropic cycle whereby eggs are infected, even these incidental hosts may serve to amplify the virus (15Go).

Recently, La Crosse virus was isolated for the first time from naturally infected Aedes albopictus (Asian tiger mosquito) reared from eggs collected around residences in eastern Tennessee and western North Carolina where La Crosse encephalitis cases have been documented (16Go). This is a nonnative mosquito but one that has spread rapidly after it was introduced in Texas in 1985 (17Go, 18Go).

This article describes the first known blinded cohort study examining the clinical, environmental, and entomological characteristics of the disease in an area in which it is now emerging. Data were collected immediately after a case of the disease was suspected but had not yet been confirmed.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Active surveillance for La Crosse infection was carried out between June 1 and September 30, 2000, at a large pediatric referral hospital located in Knoxville, Tennessee. Children were enrolled in the study if they were aged 6 months or older, had a physician-diagnosed febrile central nervous system infection, had a lumbar puncture performed, and had no evidence of a bacterial central nervous system infection or other documented disease to explain their illness. For all children meeting these criteria, an acute-phase serum specimen was obtained for testing for antibodies to La Crosse virus as part of the initial laboratory evaluation. Parents were provided information about La Crosse virus infection, and consent to participate further in the study was obtained. The involvement of human subjects (e.g., obtaining acute-phase and convalescent-phase serum samples) followed established guidelines for investigating reportable diseases in Tennessee.

Parents who gave their consent were interviewed by a public health nurse within 1 week of the child's hospital discharge. These interviews focused on personal or household characteristics such as use of insect repellent, length of time children spent outdoors, and presence of window screens in the residence. Clinical data were obtained from hospital records. For La Crosse virus cases only, information on symptoms at discharge was obtained from medical records.

Convalescent-phase serum specimens were obtained 2–4 weeks following onset of illness. Laboratory testing of paired acute-phase and convalescent-phase serum samples was performed at the Knoxville Regional Laboratory of the Tennessee Department of Health. All samples were tested for immunoglobulin G antibodies to La Crosse virus, St. Louis encephalitis, eastern equine encephalitis, and western equine encephalitis viruses by use of a commercially available indirect immunofluorescent antibody test for arboviruses (MRL Diagnostics, Cypress, California). All samples testing positive were subsequently tested for La Crosse virus at the CDC, Division of Vector-Borne Infectious Diseases, Fort Collins, Colorado, by using both enzyme-linked immunosorbent assay and plaque reduction neutralization tests.

In addition to the tests for La Crosse virus infection, some combination of serologic and cerebrospinal fluid studies was conducted for most children enrolled in the study, including those for antibodies to Coxsackieviruses, cytomegalovirus, echoviruses, herpes, influenza, mumps, measles, and varicella-zoster. For a number of these children, their cerebrospinal fluid was also tested for enteroviruses and herpes polymerase chain reaction.

Environmental assessments were conducted around the residences of study enrollees within approximately 1 week following hospital discharge. These assessments focused on characteristics such as the numbers and types of potential mosquito breeding containers, the maintenance condition of the house and grounds, and the predominant surrounding habitat (e.g., suburban, pasture, successional forest). Mosquitos were gathered by using standard oviposition traps to collect eggs (to rear to adults) and to collect larvae from water-filled containers (both artificial and natural); carbon-dioxide-baited traps from the CDC were used to gather adult mosquitos.

Detailed methodologies for the use of oviposition traps and for mosquito rearing from eggs have been described elsewhere (16Go). Briefly, 10 oviposition traps were left in place at each residence for 1 week, and one carbon-dioxide-baited CDC trap was operated for a single 24-hour period at each site. Artificial and natural containers (but not oviposition traps) were sampled for mosquito larvae, and collected larvae were removed to the laboratory for rearing to adults. Eggs were gathered from the oviposition traps only. Adult mosquitoes, reared from eggs and larvae, and adults collected in the CDC traps were separated by species and sex and then into pools of not more than 50 mosquitoes, which were frozen at -80°C for virus isolation at the CDC Division of Vector-Borne Infectious Diseases in Fort Collins. Pools of mosquitoes were processed by using the methods of Beaty et al. (19Go) and Dogget et al. (20Go) and were tested for the presence of live virus with vero cell culture plaque assay, as described by Gerhardt et al. (16Go).

All data were entered and analyzed by using EpiInfo software, version 6.0 (CDC, Atlanta, Georgia) (21Go). Categorical data were compared for confirmed La Crosse cases versus confirmed noncases by using chi-square analysis. Continuous data were analyzed by use of analysis of variance. Data shown to be not normally distributed by using Bartlett's test for homogeneity of variance were further analyzed with the Kruskal-Wallis test for two groups.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Sixty children met the criteria for initial enrollment in the study. Fourteen (23 percent) were subsequently removed from the study: three children were not in eastern Tennessee during the known incubation period for La Crosse virus, other diagnoses were subsequently confirmed for four children, and the parents of seven children refused consent for further participation. Forty-six children (77 percent) were included for subsequent interviews, environmental assessments, and mosquito collection. Of the 42 children from whom convalescent-phase serum samples were obtained, 16 (38 percent) had laboratory-confirmed La Crosse virus infection based on a fourfold increase in their antibody titers between collection of the acute- and convalescent-phase samples. When plaque reduction neutralization tests were conducted, all 16 children were confirmed positive for La Crosse infection. Mosquitos were not collected at the residences of two children because cold weather arrived as mosquito collections were scheduled to begin.

Table 1 summarizes the demographic and clinical characteristics of the 40 children for whom full data could be obtained. The mean age of children with La Crosse virus infection was 7.5 years, and 60 percent were male. Fever, headache, vomiting, and behavioral changes were the predominant symptoms, while loss of consciousness and seizures were observed less frequently. No clinical or cerebrospinal fluid findings were significantly different between confirmed La Crosse infection cases and noncases.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Demographic and clinical characteristics of children confirmed to have La Crosse encephalitis or not to have La Crosse encephalitis, eastern Tennessee, 2000

 
As shown in table 2, La Crosse infection cases differed from noncases in the reported average number of hours per day they spent outdoors (5.9 for La Crosse infection cases vs. 4.0 for noncases, p = 0.049). No statistically significant differences were noted regarding type of clothing worn, use of insect repellent, or how often windows were left open.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Family and household characteristics of children confirmed to have La Crosse encephalitis or not to have La Crosse encephalitis, eastern Tennessee, 2000

 
La Crosse virus cases were almost four times more likely than noncases to live in a residence with one or more tree holes nearby (within 100 m) (table 3) (relative risk = 3.96, p = 0.028). No statistically significant differences were noted for the number or type of potential artificial mosquito-breeding containers, other household characteristics (such as use of window screens), maintenance of house and grounds, predominant surrounding habitat, or distance from the forest line or road.


View this table:
[in this window]
[in a new window]
 
TABLE 3. Environmental assessment, comparing site of likely exposure, for children confirmed to have La Crosse encephalitis or not to have La Crosse encephalitis, eastern Tennessee, 2000

 
Results of mosquito collection activities are summarized in table 4. For three children, mosquito collection data were analyzed for a site other than the primary residence; in these situations, parents noted another more likely exposure site. The total burden of Ae. albopictus (defined as the number of female and male larvae and adults collected at the site) was more than three times greater around the residences of La Crosse virus cases versus noncases (p = 0.013). No statistically significant differences were noted regarding the total mosquito burden of Oc. triseriatus. Other mosquitoes collected at the study sites, and submitted for viral isolation, included Culex pipiens, Culex pipiens/restuans, Culex species, and Orthopodomyia signifera. During this study, no viruses were isolated from any of the mosquitoes collected at any of the sites.


View this table:
[in this window]
[in a new window]
 
TABLE 4. Mean numbers of Aedes albopictus and Ochlerotatus triseriatus mosquitoes collected as adults, larvae, or eggs at primary exposure sites of children confirmed to have La Crosse encephalitis or not to have La Crosse encephalitis, eastern Tennessee, 2000

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
This is the first known blinded cohort study of La Crosse virus that includes three major areas of investigation: clinical, environmental, and entomological. To our knowledge, Tennessee and North Carolina are the first and only locations in which La Crosse virus has been isolated from wild populations of Ae. albopictus. The entomological data from this study suggest that a high level of exposure to Ae. albopictus may be a risk factor for La Crosse infection, which may explain in part the recent emergence of La Crosse infection in Tennessee and its appearance in suburban in addition to rural areas.

In this study, no clinical or laboratory characteristics distinguished La Crosse encephalitis from the undiagnosed central nervous system infections in the enrolled children. The recent report from McJunkin et al. (22Go) on a case series of 127 children with La Crosse encephalitis also did not reveal any uniquely distinguishing clinical feature of the acute illness. In the present study, seizures occurred in 25 percent of La Crosse infection cases, a rate somewhat lower than the 40 percent noted in a study by Gundersen and Brown of 178 patients (23Go), the 46 percent noted by McJunkin et al., and the 42–60 percent reported by Rust et al. (24Go). Although seven of the 10 La Crosse infection cases for whom we had medical records data were noted to have some symptoms at discharge, only one (with tremor, decreased manual dexterity and balance, and difficulty in thinking) could be characterized as having a true neurologic deficit. McJunkin et al. reported primarily on children who had true neurologic deficits at discharge, and they noted that 12 percent of their patients had such sequelae. Rust et al. described a broader array of outcomes, including seizures, migrainous headaches, and behavioral disturbances (such as emotional lability).

Although the appearance of encephalitis may truly be similar for a variety of etiologies, there are at least two possible explanations for the absence of any uniquely distinguishing clinical characteristics of La Crosse encephalitis. First, the vast majority of non–La Crosse encephalitis cases might indeed be La Crosse encephalitis cases, not diagnosed either because they failed to develop antibodies or because the tests currently available might not be sufficiently sensitive. A second possibility is that the non–La Crosse encephalitis cases of disease represent one or more illnesses identical to La Crosse encephalitis that are also arthropod-borne. Both of these areas are important for further research.

Children with La Crosse infection spent a greater total number of hours outdoors—and a greater number of daylight hours outdoors—than children who were not infected, important since both Ae. albopictus and Oc. triseriatus are daytime feeders. Grimstad et al. (25Go) have shown that a laboratory population of Ae. albopictus was capable of transmitting La Crosse virus at rates equal to or greater than the rate observed for Oc. triseriatus. Anecdotal evidence exists that Ae. albopictus may be a more aggressive (human) biter than Oc. triseriatus (Reid Gerhardt, University of Tennessee, personal communication, 2000), further heightening the concern about this mosquito species.

La Crosse-infected children were much more likely to live in a residence with one or more tree holes nearby. This finding is consistent with that of a case-control study in West Virginia conducted by Woodruff et al. (26Go), which found an increase in risk for La Crosse infection in children who lived in households with one or more tree holes within 300 feet (90 m) of the house. The degree to which Ae. albopictus may competitively displace Oc. triseriatus for similar breeding habitat such as tree holes is not clear. Given the rapid spread of Ae. albopictus, this is an important area for future research.

The total Ae. albopictus burden was significantly higher around residences that included La Crosse-infected children versus noninfected children, but there were no such differences for Oc. triseriatus. In this study, we defined the total mosquito burden to be the number of female and male larvae and adults collected at the site, and we did not include eggs in this equation. Compared with egg collections, the presence of larvae and adults is a much better indicator of likely human exposure to biting mosquitoes at that time. Eggs may die before hatching, or they may remain dormant and not hatch until a rainfall floods the container or tree hole later in the season or during the following summer. No significant difference was found in Oc. triseriatus and Ae. albopictus egg density between case and noncase sites.

Since its 1995 arrival in a tire shipment in Houston, Texas, Ae. albopictus has spread rapidly throughout the United States and has been documented in 928 counties in 30 states (17Go, 18Go). Ae. albopictus is now the most commonly encountered mosquito in Tennessee; during 1998–2000, 100 percent of more than 100 locations in which oviposition traps were placed were positive for eggs of Ae. albopictus (Reid Gerhardt, University of Tennessee, unpublished data), and this mosquito species has been collected in all Tennessee counties (27Go). Ae. albopictus not only shares a similar ecologic niche with Oc. triseriatus—historically a forest-dwelling species—but also is now found in less-forested areas as well. This expanding range of Ae. albopictus has the potential to increase risks for La Crosse virus transmission, both in settings in which human habitation is spreading into more remote environs and in suburban sprawls.

Ae. albopictus can transmit other viruses. In its Old World habitat, Ae. albopictus has been shown to be a natural vector for dengue and may play a role in the transmission of Chikungunya, Japanese encephalitis, and other arboviruses (28Go). To date, seven viruses have been isolated from Ae. albopictus collected in the wild in the United States, including eastern equine encephalitis and Keystone, Tensaw, Potosi, Cache Valley (29Go), Jamestown Canyon (30Go), and La Crosse (16Go) viruses. Most recently, a pool of Ae. albopictus collected in the northeastern United States showed evidence of West Nile virus infection (31Go). Isolations of La Crosse virus from wild populations of Ae. albopictus in eastern Tennessee and in western North Carolina remain the only such incidences from mosquitoes collected from a location directly linked to known cases of disease in humans.

A potential limiting factor to this study is that it included only those children with overt illness, whereas the majority of La Crosse virus infections are likely to be asymptomatic or subclinical. It is not known whether risk factors, including exposure to multiple potential vectors, differ between those who become seriously ill and those who remain asymptomatic. Although laboratory strains of Ae. albopictus may be capable of transmitting La Crosse virus at rates equal to or greater than that observed for Oc. triseriatus (25Go), it is not clear whether these differences appear in nature. It is equally unclear whether differences in the infectious dose of La Crosse virus could account for the differences in clinical presentation.

Attempts to control or prevent La Crosse virus infection may be aimed at both mosquitoes and humans. Although it is not clear whether modifying the natural habitat—such as filling tree holes—affects the mosquito burden, it seems reasonable for people to keep the number of man-made breeding containers at a minimum, especially when children are present. The use of mosquito repellent remains a logical preventive measure, although changing people's behavior so they use repellent before being bitten rather than as a response to mosquito bites, remains a challenge. Efforts to develop a La Crosse virus vaccine are ongoing; however, it may be exceedingly difficult to implement a cost-effective and appropriate vaccination program given the high numbers of asymptomatic cases.

Finally, it is unclear whether or how further spread of Ae. albopictus can be limited. As this nonnative species expands its range in the United States, concerns about its ability to transmit other viruses—including West Nile virus—will likely increase. Turell et al. (32Go) recently showed Ae. albopictus to be highly susceptible to infection by West Nile virus. Given the now-proven capability of Ae. albopictus to transmit La Crosse virus, the possibilities of its transmitting viruses that cause much greater mortality remain real.


    ACKNOWLEDGMENTS
 
The authors thank Caroline Graber of the East Tennessee Children's Hospital for patient information; Dr. Phil Baker and Judy Tharpe of the Knoxville Regional Laboratory of the Tennessee Department of Health for laboratory support; Dr. Stephanie Hall and Maria Powers of the Knox County Health Department for assistance in conducting surveillance activities; and Sandra Hardin, Meredith Hitch, and Lindsay Jones of the East Tennessee Regional Health Office for assistance in coordinating surveillance activities.


    NOTES
 
Reprint requests to Dr. Paul Campbell Erwin, East Tennessee Regional Office, Tennessee Department of Health, 1522 Cherokee Trail, Knoxville, TN 37920 (e-mail: perwin{at}mail.state.tn.us).


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Summary of notifiable diseases, United States, 1998. MMWR Morb Mortal Wkly Rep 1999;47:5–6.
  2. Tsai TF. Arboviral infections in the United States. Infect Dis Clin North Am 1991;5:73–103.[Medline]
  3. Provisional data. MMWR Morb Mortal Wkly Rep 2000;49:1167–74.
  4. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994;7:89–116.[Abstract]
  5. Grimstad PR, Barrett CL, Humphrey RL, et al. Serologic evidence for widespread infection with La Crosse and St. Louis encephalitis viruses in the Indiana human population. Am J Epidemiol 1984;119:913–30.[Abstract]
  6. Thompson WH, Kalfayan B, Anslow RO. Isolation of California encephalitis group virus from a fatal human illness. Am J Epidemiol 1965;81:245–53.[ISI]
  7. Nacsi RS, Moore CG, Biggerstaff BJ, et al. La Crosse encephalitis virus habitat associations in Nicholas County, West Virginia. J Med Entomol 2000;37:559–70.[ISI][Medline]
  8. Szumlas DE, Apperson CS, Hartig PC, et al. Sero-epidemiology of La Crosse virus infection in humans in western North Carolina. Am J Trop Med Hyg 1996;54:332–7.[ISI][Medline]
  9. Jones TF, Craig AS, Nasci RS, et al. Newly recognized focus of La Crosse encephalitis in Tennessee. Clin Infect Dis 1999;28:93–7.[ISI][Medline]
  10. Jones TF, Erwin PC, Craig AS, et al. Serological survey and active surveillance for La Crosse virus infections among children in Tennessee. Clin Infect Dis 2000;31:1284–7.[ISI][Medline]
  11. Watts DM, Morris CD, Wright RE, et al. Transmission of La Crosse virus (California encephalitis group) by the mosquito Aedes triseriatus. J Med Entomol 1972;9:125–7.[ISI][Medline]
  12. Thompson WH, Beaty BJ. Venereal transmission of La Crosse virus from male to female Aedes triseriatus. Am J Trop Med Hyg 1978;27:187–95[ISI][Medline]
  13. Watts DM, Pantuwatana S, DeFoliart GR, et al. Transovarial transmission of La Crosse virus (California encephalitis group) in the mosquito Aedes triseriatus. Science 1973;182:1140–3.[ISI][Medline]
  14. Watts DM, Thompson WH, Yuill TM, et al. Overwintering of La Crosse virus in Aedes triseriatus. Am J Trop Med Hyg 1974;23:694–700.[Medline]
  15. Osorio JE, Godsey MS, Defoliart GR, et al. La Crosse virus in white-tailed deer and chipmunks exposed by injection or mosquito bite. Am J Trop Med Hyg 1996;54:338–42.[ISI][Medline]
  16. Gerhardt RR, Gottfried KL, Apperson CS, et al. The first isolation of La Crosse encephalitis virus from naturally infected Aedes albopictus. Emerg Infect Dis 2001;7:807–11.[ISI][Medline]
  17. Sprenger D, Wuithiranyagool T. The discovery and distribution of Aedes albopictus in Harris County, Texas. J Am Mosq Control Assoc 1986;2:217–19.[ISI][Medline]
  18. Moore CG, Mitchell CJ. Aedes albopictus in the United States: ten-year presence and public health implications. Emerg Infect Dis 1997;3:329–34.[ISI][Medline]
  19. Beaty BJ, Calisher CH, Shope RS. Arboviruses. In: Schmidt NJ, Emmons RW, eds. Diagnostic procedures for viral, rickettsial and chlamydia infections. Washington, DC: American Public Health Association, 1989:797–856.
  20. Dogget SL, Koevski I, Haniotis J, et al. "MOSAVEX": a mechanical device to grind mosquitoes for arbovirus detection. Arbovirus Res Australia 1997;7:75–8.
  21. Dean AD, Dean JQ, Coulombier D, et al. Epi Info. Version 6: a word processing, database and statistics program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
  22. McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med 2001;344:801–7.[Abstract/Free Full Text]
  23. Gundersen CB, Brown KL. Clinical aspects of La Crosse encephalitis: preliminary report. In: Calisher CH, Thompson WH, eds. California serogroup viruses. New York, NY: Alan R Liss, Inc, 1983:169–77.
  24. Rust RS, Thompson WH, Matthews CG, et al. La Crosse and other forms of California encephalitis. J Child Neurol 1999:14:1–14.[ISI][Medline]
  25. Grimstad PR, Kobayashi JF, Zhang M, et al. Recently introduced Aedes albopictus in the United States: potential vector of La Crosse virus (Bunyaviridae: California serogroup). J Am Mosq Control Assoc 1989;5:422–7.[ISI][Medline]
  26. Woodruff BA, Baron RC, Tsai TF. Symptomatic La Crosse virus infections of the central nervous system: a study of risk factors in an endemic area. Am J Epidemiol 1992;136:320–7.[Abstract]
  27. Moore JP. Aedes albopictus (Diptera: Culicidae) occurrence throughout Tennessee, with biological notes. Entomol News 1998;109:363–5.[ISI]
  28. Hawley WA. The biology of Aedes albopictus. J Am Mosq Control Assoc 1988;4:2–39.
  29. Mitchell CJ, Haramis LD, Karabatsos N, et al. Isolation of La Crosse, Cache Valley, and Potosi viruses from Aedes mosquitoes (Diptera: Culicidae) collected at used-tire sites in Illinois during 1994–95. J Med Entomol 1998;35:573–7.[ISI][Medline]
  30. Gottfried KL, Gerhardt RR, Nasci RS, et al. Temporal abundance, parity, survival rates and arbovirus isolation of field collected container-inhabiting mosquitoes in eastern Tennessee. J Am Mosq Control Assoc (in press).
  31. Update: West Nile virus activity—eastern United States, 2000. MMWR Morb Mortal Wkly Rep 2000;49:1044–7.[Medline]
  32. Turell MJ, O'Guinn ML, Dohm DJ, et al. Vector competence of North American mosquitoes (Diptera: Culicidae) for West Nile virus. J Med Entomol 2001;38:130–4.[ISI][Medline]
Received for publication May 25, 2001. Accepted for publication January 11, 2002.





This Article
Abstract
FREE Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Search for citing articles in:
ISI Web of Science (2)
Disclaimer
Request Permissions
Google Scholar
Articles by Erwin, P. C.
Articles by Schaffner, W.
PubMed
PubMed Citation
Articles by Erwin, P. C.
Articles by Schaffner, W.